Maravai Lifesciences Holdings
Quarterly Financials
| Values in thousands | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 |
|---|---|---|---|---|
Revenue | $73,400 | $64,179 | $74,141 | $66,865 |
Gross Profit | 28,260 | 18,975 | 38,433 | 30,179 |
EBITDA | 2,734 | -3,501 | 13,193 | -5,534 |
EBIT | -11,813 | -17,254 | 213 | -18,630 |
Net Income | -7,585 | -12,078 | -105,959 | -6,462 |
Net Change In Cash | 73,400 | 64,179 | 74,141 | 66,865 |
Free Cash Flow | 7,881 | -14,132 | -9,009 | -1,661 |
Cash | 573,171 | 561,691 | 574,962 | 579,605 |
Basic Shares | 135,842 | 132,333 | 132,139 | 131,930 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $288,945 | $883,001 | $799,240 | $284,098 |
Gross Profit | 137,602 | 714,044 | 658,679 | 204,449 |
EBITDA | 44,584 | 568,396 | 543,675 | 93,434 |
EBIT | -4,197 | 530,293 | 518,923 | 67,597 |
Net Income | -119,029 | 490,663 | 469,250 | 76,888 |
Net Change In Cash | 288,945 | 883,001 | 799,240 | 284,098 |
Cost of Revenue | 315,176 | |||
Free Cash Flow | 60,671 | 518,887 | 353,720 | 126,779 |
Cash | 574,962 | 632,138 | 551,272 | 236,184 |
Basic Shares | 131,919 | 255,323 | 257,803 | 96,646 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-03-31 | -$0.02 |
2024-06-30 | -$0.05 |
2024-03-31 | -$0.02 |
2023-12-31 | $0.01 |
